Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05626049 · ClinicalTrials.gov registry record · NA

Implementation of the ACP Guideline for Low Back Pain (IMPACt-LBP)

A NA study of Pain, Back, sponsored by Duke University.

Active
Registry status
NA
Development phase
1,800
Enrollment target
3
Study locations

NCT05626049 is a NA study of Pain, Back that is active but no longer recruiting, run by Duke University. The registered enrollment target is 1,800 participants, above the 75-participant average among 7 other Pain, Back trials with a reported enrollment target (2300% higher). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05626049, a NA study of Pain, Back, is active but no longer recruiting, sponsored by Duke University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,800 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to assess whether the primary spine practitioner (PSP) model of care will lead to improvements in patient outcomes, as compared to usual care, based on change in patient-reported PROMIS Pain Interference and Physical Function from baseline to 3 months in patients aged 18 years and older with a primary complaint of low back pain (LBP).

Conditions Studied

Interventions

  • OTHER Usual Care
  • OTHER Primary Spine Provider Model

Study Locations (3)

Iowa

  • University of Iowa - Iowa City

New Hampshire

  • Dartmouth Health - Lebanon

North Carolina

  • Duke Health - Durham

Trial Details

FieldValue
Enrollment Target 1,800 participants
Start Date 2023-03-14
Est. Completion 2026-06-30
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT05626049

The ClinicalTrials.gov registry entry for NCT05626049 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,800 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 75-participant average among 7 other Pain, Back trials with a reported enrollment target (2300% higher). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain, Back appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT05626049 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Iowa, New Hampshire, North Carolina.

Frequently Asked Questions

What is clinical trial NCT05626049 about?

NCT05626049 is a clinical study titled "Implementation of the ACP Guideline for Low Back Pain (IMPACt-LBP)". The purpose of this study is to assess whether the primary spine practitioner (PSP) model of care will lead to improvements in patient outcomes, as compared to usual care, based on change in patient-reported PROMIS Pain Interference and Physical Function from baseline to 3 months in patients aged 18...

What is the current status of trial NCT05626049?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,800 participants. The study started on 2023-03-14. Estimated completion is 2026-06-30.

What conditions does trial NCT05626049 study?

This clinical trial studies the following conditions: Pain, Back.

What interventions are being tested in trial NCT05626049?

The interventions under investigation include: Usual Care (OTHER), Primary Spine Provider Model (OTHER).

Who is sponsoring clinical trial NCT05626049?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05626049 being conducted?

This trial has 3 study locations across Iowa, New Hampshire, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Back

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.